Emergências e Terapia Intensiva
Resumo da nova diretriz AHA/ASA 2022 sobre hemorragia intracerebral.
22 Jun, 2022 | 21:26hIntracerebral Hemorrhage 2022 Guideline Update – emDocs
Principais tópicos a saber: 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage – American Heart Association
Comunicado de imprensa: New guideline refines care for brain bleeds: compression socks, some meds not effective – American Heart Association
Estudo randomizado | Uma estratégia de restrição de fluidos intravenosos não melhora os desfechos em pacientes em UTI com choque séptico.
21 Jun, 2022 | 13:14hRestriction of Intravenous Fluid in ICU Patients with Septic Shock – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentário: No Fewer Deaths Seen With Restricted IV Fluid for Septic Shock – HealthDay
Conteúdos relacionados:
Fluid administration and monitoring in ARDS: which management? – Intensive Care Medicine
Comentário no Twitter
In this trial, a restrictive approach to intravenous fluid administration in critically ill patients with septic shock did not reduce mortality. #CCR22 https://t.co/UfY1936Qwb pic.twitter.com/FtSaDIIroj
— NEJM (@NEJM) June 17, 2022
[Preprint] Estudo randomizado aberto | Baricitinibe é não inferior ao tocilizumabe em pacientes internados com COVID-19 grave.
21 Jun, 2022 | 13:01hConteúdos relacionados:
WHO recommends two new drugs to treat COVID-19 – World Health Organization
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 – New England Journal of Medicine
Comentário no Twitter
Preprint⚡⚡
Baricitinib Vs Tocilizumab open label RCT
Baricitinib was non-inferior to tocilizumab with regards to the composite outcome of mechanical ventilation or death by day 28 and the time to discharge by day 28 in patients with severe #COVID19 https://t.co/sQkhATkjEd— Antibiotic Steward Bassam Ghanem🆔🔥 (@ABsteward) June 16, 2022
Breve revisão | Suporte não invasivo por capacete na insuficiência respiratória hipoxêmica.
21 Jun, 2022 | 12:50hHelmet noninvasive support in hypoxemic respiratory failure – Intensive Care Medicine (se o acesso a este link for pago, tente este)
Comentário no Twitter
Helmet noninvasive support in hypoxemic respiratory failure:
⚙️ set‐up
⛑ physiology of helmet interface: from most relevant feature to major drawbacks
💨 clinical implications
Free to read #FOAMcc on @yourICM
🖇 https://t.co/qNE4Id5oBg pic.twitter.com/b2auLLlW9z— Intensive Care Medicine (@yourICM) June 18, 2022
Estudo randomizado | Aumento da imunidade com timosina alfa-1 não melhora os desfechos em pacientes com pancreatite necrotizante aguda grave prevista.
21 Jun, 2022 | 12:45hImmune enhancement in patients with predicted severe acute necrotising pancreatitis: a multicentre double-blind randomised controlled trial – Intensive Care Medicine (se o acesso a este link for pago, tente este)
Estudo de coorte com base em registro | Tratamento endovascular vs. melhor tratamento clínico em AVC por oclusão aguda de artéria basilar.
19 Jun, 2022 | 17:07hEndovascular Treatment Versus Best Medical Management in Acute Basilar Artery Occlusion Strokes: Results From the ATTENTION Multicenter Registry – Circulation (gratuito por tempo limitado)
Comentário no Twitter
#ResearchLetter In 2134 patients with basilar artery occlusion #stroke, endovascular treatment was associated with improved functional capacity. The effect was more pronounced in patients with more debilitating symptoms #AHAJournals https://t.co/wy4uFocYlR pic.twitter.com/TIBRVAXRhE
— Circulation (@CircAHA) June 10, 2022
#CCR22 – Estudo randomizado | Vitamina C intravenosa aumenta o risco de morte ou disfunção persistente de órgão em adultos com sepse em UTI.
19 Jun, 2022 | 17:03hConteúdos relacionados:
Comentário no Twitter
In this trial of IV vitamin C in adult patients with sepsis, those who received a vitamin C infusion had a higher risk of death or persistent organ dysfunction at 28 days than those who received placebo. #CCR22 https://t.co/8tpW7Yud6a pic.twitter.com/1Jf9aIka8Y
— NEJM (@NEJM) June 15, 2022
#CCR22 – Estudo randomizado | Terapia com cânula nasal de alto fluxo atinge critério de não inferioridade em comparação ao CPAP na liberação do suporte respiratório em crianças criticamente doentes em UTI.
19 Jun, 2022 | 17:01hEffect of High-Flow Nasal Cannula Therapy vs Continuous Positive Airway Pressure Therapy on Liberation From Respiratory Support in Acutely Ill Children Admitted to Pediatric Critical Care Units: A Randomized Clinical Trial – JAMA (gratuito por tempo limitado)
Comentário no Twitter
Among acutely ill children clinically assessed to require noninvasive respiratory support in a pediatric critical care unit, HFNC met the criterion for noninferiority compared with CPAP for time to liberation from respiratory support. https://t.co/WvU2fKLDOJ #CCR22
— JAMA (@JAMA_current) June 16, 2022
#CCR22 – Estudo randomizado | Entre pacientes críticos submetidos a intubação traqueal, administrar 500 mL de fluido em bolus não diminui a incidência de hipotensão arterial grave, parada cardíaca ou morte.
19 Jun, 2022 | 16:59hEffect of Fluid Bolus Administration on Cardiovascular Collapse Among Critically Ill Patients Undergoing Tracheal Intubation: A Randomized Clinical Trial – JAMA (gratuito por tempo limitado)
Comentário no Twitter
In this randomized clinical trial, among critically ill adults undergoing tracheal intubation, administration of a fluid bolus did not significantly decrease the incidence of cardiovascular collapse. https://t.co/vPkfgLBF1n #CCR22
— JAMA (@JAMA_current) June 16, 2022
Revisão | Os fundamentos fisiológicos do suporte respiratório.
19 Jun, 2022 | 16:10hThe physiological underpinnings of life-saving respiratory support – Intensive Care Medicine
Comentário no Twitter
Physiology of life-saving respiratory support:
➡️historical overview
➡️pathophysiology of respiratory failure
Invasive mechanical ventilation & extracorporeal support #ECLS #ECMO:
➡️rationale
➡️implementation
➡️iatrogenic consequences
➡️future#FOAMcc
📎 https://t.co/EEvfpqVKIa pic.twitter.com/4t7wl53Jpz— Intensive Care Medicine (@yourICM) June 12, 2022